Tag :

drug discovery Press Releases

Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing

Morphogen-IX Ltd, a biotechnology company focused on the development of bone morphogenetic proteins (BMPs) for the treatment of pulmonary arterial hypertension (PAH), today announced completion of a £18.4 million round of financing. The Series B was led by Medicxi, alongside investments from Cambridge…

Morphogen-IX Announces MGX292 as Clinical Development Candidate

​Morphogen-IX Ltd, a biotechnology company focused on the development of bone morphogenetic proteins (BMPs) for the treatment of pulmonary arterial hypertension (PAH), today announced the nomination of its clinical development candidate and initiation of formal preclinical development. The agent, MGX292,…

RxCelerate Opens UK-Based Chemistry Operations at the University of Warwick

RxCelerate Opens UK-Based Chemistry Operations at the University of Warwick

RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has opened UK-based chemistry operations at The University of Warwick. The new operation will be led by Dr Nigel Ramsden, who joins RxCelerate…

Better Target Validation for Drug Discovery With CRISPR/Cas9, New Webinar Hosted by Xtalks

Join our keynote speaker, Jon Moore, CSO at Horizon Discovery, for a live session on Tuesday, Oct. 23, 2018. Horizon Discovery has used CRISPR/Cas9 to perform pooled screens of a 3,000-gene library, that includes protein and lipid kinases against a panel…

TARA Biosystems Announces Launch of Cardiotype.Fo, Best-in-Class In Vitro Assay for Assessment of Cardiac Contractility

TARA Biosystems Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and development applications, announced today the launch of Cardiotype.Fo, the best-in-class in vitro system for assessment of cardiac contractility. Contractility of heart muscle tissue is a critically important measure…

Genome-Scale CRISPR Screens: Strategies to Prioritise and Validate Potential Targets, New Webinar Hosted by Xtalks

Extracting the most relevant biological data from such studies can seem daunting but, with the correct strategy, can be incredibly rewarding. Drug discovery is a challenging process that is often hindered by inefficient target identification. Functional genomics has the potential to…

Upcoming Xtalks Webinar: How the New FDA Drug-Drug Interaction Guidance Fits Within the Drug Development De-Risking Model

If all the molecules in discovery and development were added together over recent years and compared to the number of successful drug approvals each year, the ratio is (approximately) 10,000:1. [1] In other words, for every 10,000 molecules entering drug discovery,…

RxCelerate Sponsors Rising Tennis Star Joanna Garland

RxCelerate, the world-leading out-sourced drug development platform announced today a sponsorship deal with 16 yr old Joanna Garland, a leading player on the international junior tennis circuit. The Stevenage, UK, based player reached the Quarter Finals of the girls singles…

Morphogen-Ix Appoints CEO and Forms Global Scientific Advisory Board

​Morphogen-IX, a preclinical biotechnology company focused on the development of bone morphogenetic proteins for the treatment of pulmonary arterial hypertension (PAH), today announced the appointment of Professor Nick Morrell as CEO.  Morrell co-founded the company in 2015 based on research…

Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks

Whether this is biologics experimental data recorded as part of a cell line development, upstream, downstream or analytical processes, or result and raw data generated through instrumentation, extracting, analyzing and reporting on this data in different formats, from disparate sources, can…

Crystallization Development – From Solid Form Screening to a GMP Crystallization Process, New Webinar Hosted by Xtalks

The aim of a crystallization process is to produce the optimal solid form with all desired properties such as particle size, particle shape, bulk density, purity, yield, residual solvent content, etc. In order to reach this goal, many steps need…

Creating Compound Screening Libraries That Address the Challenges of Drug Discovery, New Webinar Hosted by Xtalks

The identification of high-quality, innovative small molecule lead compounds remains a challenge in drug discovery. Access to innovative compound libraries is crucial in order to address the challenges associated with discovering new drugs. The chemical space to be sampled in…

Blockchain Beyond Cryptocurrency: Applying Blockchain Technology to the Life Sciences, New Webinar Hosted by Xtalks

Join featured speakers Christopher Petersen, Co-Founder of Scientist.com, Andrew Hessel, PhD, CEO of Humane Genomics Inc. and Ron Ranauro, Founder of Incite Advisors/TrialIO, for an informative session focusing on the topic of how blockchain technology can be used in the…

TARA Biosystems' CEO Misti Ushio Named to Fast Company's Top 100 Most Creative People in Business

TARA Biosystems Inc., a company offering physiologically relevant, human “heart-on-a-chip” tissue-models for drug discovery and development applications, is proud to announce that TARA CEO Dr. Misti Ushio has been recognized by Fast Company as one of the Top 100 Most Creative…

Human Biological Samples: Promoting Collaboration Within the Research Community to Advance Drug Discovery, New Webinar Hosted by Xtalks

Join us for an informative live session on Monday, May 14, 2018 at 9:30 a.m. EDT (2:30 p.m. BST/UK), surrounding the topic of collaboration and the use of human biological samples. Hear from experts in biobanking, governing bodies and commercial…

Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks

In this live presentation, featured speakers from KCAS Gene Ray, Ph.D., Senior Scientific Advisor and Lawrence Goodwin, Executive Director of Bioanalytical R&D and LC-MS/MS Services will highlight bioanalytical challenges in drug discovery and some potential solutions. Examples to be presented…

Leading UK Drug Developer RxCelerate Opens First US Base in Boston

Leading UK Drug Developer RxCelerate Opens First US Base in Boston

RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has hired Laura Hamilton as Executive Vice President, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston. “We are bringing…

Consortium secures Innovate UK funding for new antibiotics

Consortium secures Innovate UK funding for new antibiotics

The UK's premier industrial biotechnology company Ingenza is working with the National Physical Laboratory and the University of Plymouth to develop a design and manufacturing platform for the production of a new family of antibiotics. The consortium has secured £933k…

SBIR-Funded Pulmotect Selected to Exhibit at 2017 BIO International Convention "Innovation Zone"

SBIR-Funded Pulmotect Selected to Exhibit at 2017 BIO International Convention "Innovation Zone"

Pulmotect, Inc., a clinical-stage biotechnology company developing and commercializing an inhalant designed to treat respiratory infections, was selected by the National Science Foundation (NSF) and the National Institutes of Health (NIH) to be featured in an Innovation Zone at the…

Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen

Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen

The Echelon LPLA2 Inhibitor Screen (K-7000I) is a fluorogenic, high-throughput assay designed to identify problem compounds early in the drug discovery process leading to safer medicine.Human lysosomal phospholipase A2 (LPLA2) is responsible for normal lipid metabolism and it is unique…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login